With three mergers totaling more than $110 billion in just the past week, 2014 could be the year of the megamerger, as cash-rich companies hunt for growth.» Read More
Stocks rose to fresh 15-month highs Tuesday, led by health-care stocks as a key Senate-seat vote in Massachusetts today could change the course of health-care reform. Citigroup bounced back after an initial dip on disappointing results.
Stocks rallied Tuesday, led by health-care stocks as a key Senate-seat vote in Massachusetts today could change the course of health-care reform. Citigroup bounced back after an initial dip on disappointing results.
Stocks pushed higher, buoyed by gains in drug and chip stocks. Citigroup bounced back after an initial dip on disappointing results.
It's early, but sell the news is the mantra so far for earnings. Stock are futures down, bonds and the dollar are up this morning. The S&P 500 recorded its largest down day in almost a month last Thursday, despite a good report from Intel. In-line (Citi) or even slightly better than expected earnings (Intel) may not be good enough...
Wall Street investors returned from a long weekend undecided about how to trade, with stock index futures pointing to little change at the open. But earnings from Citigroup could dictate direction from the opening bell.
What follows is a roundup of corporate earnings reports for Tuesday, Jan. 19.
The Bureau of Labor Statistics doesn't release its official jobs report until Friday but there is lots of preamble.
We are putting cash back to work, said Ron Muhlenkamp, portfolio manager at The Muhlenkamp Fund, and Jeff Mortimer, CIO of Charles Schwab Investment Management.
The slumping economy negatively impacted many smaller companies that reported earnings on Tuesday. The following are some firms that reported earnings before the opening bell:
Markets are bracing for a landslide of earnings news Tuesday and more focus on the Treasury's bank bailout plans.
The Dow rallied for a third day on Thursday, and traded above 8,000 for the first time since early February on an intra-day basis.
Generic drug company Forest Labs is seeing heavy call activity amid buyout rumors.
Forget about mergers and acquisitions (M & A). Think about partnerships and acquisitions or what Leerink Swann, which specializes in healthcare stock coverage, is calling "P & A."
Movement in a few key sectors could give stocks a much-needed boost.
Ever wonder how these people decide which stock's a buy and which is a sell? Now you know.
Depends on which analyst you believe. Find out who Cramer's siding with.
Following are the day’s biggest winners and losers. Find out why shares of Staples and Honda popped while Nokia and ConAgra dropped.
Scott Richter, portfolio manager of the Fifth Third Disciplined Fund, prescribes two stocks in the pharmaceuticals sector.
To give investors an edge, CNBC asked the market experts for their best trades now.
Mary Jane Matts knows a few things about "up" stocks in a "down" market, and she's sharing a couple of suggestions with CNBC.